MedTrace Logo

Lynparza Ovarian Cancer Clinical Experience Investigation (All Case Investigation)

NCT03505307 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 846

Last updated 2022-06-01

No results posted yet for this study

Summary

\[Objectives\] Objectives include following to capture safety and efficacy of LYNPARZA in actual clinical use.

1. ADR development in actual clinical use
2. Factors which may affect safety and efficacy
3. ADRs not expected from "Precautions for Use"

Conditions

Sponsors & Collaborators

Principal Investigators

  • Toshimitsu Tokimoto · AstraZeneca KK

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-21
Primary Completion
2020-12-07
Completion
2020-12-07

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03505307 on ClinicalTrials.gov